<DOC>
	<DOCNO>NCT00467740</DOCNO>
	<brief_summary>The primary objective study determine optimum dose ( ) BI 1744 CL inhalation solution deliver Respimat® inhaler four week patient asthma . The selection optimum dose ( ) base bronchodilator efficacy ( well help breathe ) , safety evaluation pharmacokinetic evaluation ( amount medication find blood ) .</brief_summary>
	<brief_title>Efficacy Safety 4 Weeks Treatment With Inhaled BI 1744 CL Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<criteria>1 . All patient must sign informed consent consistent ICHGCP guideline prior participation trial , include medication washout restriction 2 . Male female patient , 18 year age old 3 . Diagnosis asthma ( GINA ) 4 . Prebronchodilator FEV1 great equal 60 % predict &lt; 90 % predict ( ECSC ) ; 5 . Increase FEV1 great equal 12 % 200 ml 15 minute 400µg salbutamol ( albuterol ) Visit 1 6 . Patient must take Inhaled Corticosteroids least 12 week prior screen , must receive stable low/moderate dose least 6 week prior screen . 7 . Patients must able perform technically acceptable pulmonary function test PEF measurement , must able maintain record ( Patient Daily eDiary ) study period require protocol 8 . Patients must able inhale medication competent manner Respimat® inhaler meter dose inhaler ( MDI ) . 1 . Patients smoke history 10 pack year 2 . Patients follow condition : diagnosis thyrotoxicosis , diagnosis paroxysmal tachycardia ( &gt; 100 beat per minute ) , mark baseline prolongation QT/QTc interval ( e.g. , repeated demonstration QTc interval &gt; 450 m ) , history additional risk factor Torsade de Pointes ( TdP ) ( e.g. , heart failure , hypokalemia , family history Long QT Syndrome ) 3 . Patients follow condition : history myocardial infarction within 1 year screen visit ( Visit 1 ) , diagnosis clinically relevant cardiac arrhythmia , history cor pulmonale , know active tuberculosis , malignancy patient undergone resection , radiation therapy chemotherapy within last five year ( patient treat basal cell carcinoma allow ) , history lifethreatening pulmonary obstruction , history cystic fibrosis , clinically evident bronchiectasis , history significant alcohol drug abuse 4 . Patients undergone thoracotomy pulmonary resection 5 . Patients take investigational drug within one month six half life ( whichever great ) prior Screening Visit ( Visit 1 ) 6 . Pregnant nursing woman 7 . Women childbearing potential use highly effective method birth control . Female patient consider childbearing potential unless surgically sterilise hysterectomy bilateral tubal ligation , postmenopausal least 2 year 8 . Patients previously randomize study currently participate another study 9 . Patients unable comply pulmonary medication restriction prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>